Cover for July

The FDA has approved Crenessity for managing classic CAH in patients 4 years and up, reducing steroid doses while controlling hormones, offering a safer treatment option.

A discussion of the evolving landscape of diabetes technology and its implications for primary care providers.

Prenatal exposure to antiseizure medications like valproate and topiramate raises risks of ASD, ADHD, and ID in children; lamotrigine shows no increased risk.

In this episode, the panel discusses therapies and care around inpatients including mechanical ventilation, extracorporeal membrane oxygenation (ECMO), and remdesivir.